Marc Ferrer, Ph.D.

Acting Branch Chief of the Early Translational Branch and Director of the 3D Tissue Bioprinting Laboratory at the National Center for Advancing Translational Sciences (NCATS) at the NIH.

Marc graduated with a BSc degree in Organic Chemistry from the University of Barcelona, Spain, in 1989, and received his Ph.D. degree in Biological Chemistry from the University of Minnesota, in 1994.  He was a postdoctoral fellow at Harvard University from 1995-1999, where he used structure-based chemical approaches for the development of anti-HIV small molecules. He joined the Department of Automated Biotechnology at the Merck Research Laboratories in 1999, where he became Director of Assay Development and High Throughput Screening.

In 2010, he joined the NIH Chemical Genomics Center working on the discovery of small molecule probes to study protein function.  In the last six years, he has led the implementation of the 3D Tissue Bioprinting Laboratory, a multidisciplinary group with the goal of creating and using 3D bioengineered tissues for disease modeling and as predictive assay platforms for drug discovery and development.  Dr. Ferrer has co-authored more than 120 peer-reviewed scientific publications.